found the clinical significance and prognostic value of FOXP3, PD-1/PD-L1 and tumor-infiltrating lymphocytes in MBC and confirmed that immunotherapy may be a potential treatment for part patients with MBC (36). Here, FOXP3 is linked to neoplasm.